Health
COVID-19 Testing Stocks Move Lower After Abbott Receives EUA For 15-Minute Test – Benzinga
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen …
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen test.
Abbott’s BinaxNOW could be transformative, Morgan Stanley analyst David Lewis said in a note.
The test is bigger and better than expected, given the $5 price point; the fact that it’s a nasal swab; its better-than-expected performance; and a higher shipment volume, the analyst said.
The Sympathy Move: The announcement, though catalyzing…
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoCountdown on for Noosa Eat & Drink Festival 2025
-
Noosa News18 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News20 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common